Susan Desmond-Hellmann - Apr 27, 2023 Form 4 Insider Report for PFIZER INC (PFE)

Role
Director
Signature
Susan E. Grant, by power of atty., for Susan Desmond-Hellmann
Stock symbol
PFE
Transactions as of
Apr 27, 2023
Transactions value $
$205,000
Form type
4
Date filed
4/28/2023, 04:33 PM
Previous filing
Apr 29, 2022
Next filing
Apr 26, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PFE Phantom Stock Units Award $205K +5.29K +35.4% $38.74 20.2K Apr 27, 2023 Common Stock 5.29K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each unit represents one phantom share of common stock.
F2 Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors.
F3 These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.